# Karl Insogna

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/karl-insogna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,041 |
| Field | Bone health and treatments |
| h-index | 78 |
| i10-index | 200 |
| Last Known Institution | Yale University |
| OpenAlex ID | https://openalex.org/A5075013519 |
| ORCID iD | https://orcid.org/0000-0001-6973-5679 |
| Works | 332 |

## Researcher papers

- [A clinician's guide to X-linked hypophosphatemia](https://scholariq.org/papers/a-clinician-s-guide-to-x-linked-hypophosphatemia/)
- [A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis](https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-phase-3-trial-evaluating-the/)
- [Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia](https://scholariq.org/papers/randomized-trial-of-the-anti-fgf23-antibody-krn23-in-x-linked-hypophosphatemia/)
- [Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group](https://scholariq.org/papers/diagnosis-and-management-of-osteopetrosis-consensus-guidelines-from-the/)

## Researcher topics

- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)
- [Vitamin D Research Studies](https://scholariq.org/topics/vitamin-d-research-studies-2/)

## Researcher university

- [Yale University](https://scholariq.org/institutions/yale-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.